Ischemia reperfusion injury as a modifiable therapeutic target for cardioprotection or neuroprotection in patients undergoing cardiopulmonary resuscitation

Resuscitation

Volumn 105, Issue , 2016, Pages 85-91

  Madathil, Ronson J ^a   Hira, Ravi S ^a   Stoeckl, Mathias ^b   Sterz, Fritz ^b   Elrod, JoAnn Broeckel ^a   Nichol, Graham ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Cardiac arrest; Conditioning; Necrosis; Propofol; Reperfusion injury

Indexed keywords

MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

COOLING; HEART PROTECTION; HUMAN; INDUCED HYPOTHERMIA; LIMB ISCHEMIA; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; RESUSCITATION; REVIEW; RISK REDUCTION; BRAIN ISCHEMIA; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; ISCHEMIC PRECONDITIONING; OUT OF HOSPITAL CARDIAC ARREST; PROCEDURES;

BRAIN ISCHEMIA; CARDIOPULMONARY RESUSCITATION; HUMANS; HYPOTHERMIA, INDUCED; ISCHEMIC PRECONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEUROPROTECTION; OUT-OF-HOSPITAL CARDIAC ARREST; REPERFUSION INJURY;

EID: 84973401309     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2016.04.009     Document Type: Review

References (111)

1. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a sepsis-like syndrome. Circulation 2002, 106:562-568.
2. Shyu K.G., Chang H., Lin C.C., et al. Concentrations of serum interleukin-8 after successful cardiopulmonary resuscitation in patients with cardiopulmonary arrest. Am Heart J 1997, 134:551-556.
3. Gando S., Nanzaki S., Morimoto Y., et al. Alterations of soluble L- and P-selectins during cardiac arrest and CPR. Intensive Care Med 1999, 25:588-593.
4. Bottiger B.W., Motsch J., Bohrer H., et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995, 92:2572-2578.
5. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135.
6. Gando S., Kameue T., Nanzaki S., et al. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 1997, 77:278-282.
7. Laurent I., Adrie C., Vinsonneau C., et al. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005, 46:432-437.
8. Vgontas A.N., Bixler E.O., Lin H.-M., et al. I-6 and its circadian secretion in humans. Neuroimmunomodulation 2005, 12:131-140.
9. Adrie C., Laurent I., Monchi M., et al. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome. Curr Opin Crit Care 2004, 10:208-212.
10. Niemann J.T., Rosborough J.P., Youngquist S., et al. Cardiac function and the proinflammatory cytokine response after recovery from cardiac arrest in swine. J Interferon Cytokine Res 2009, 29:749-758.
11. Bisschops L., van der Hoeven J.G., Mollnes T.E., et al. Seventy-two hours of mild hypothermia after cardiac arrest is associated with a lowered inflammatory response during rewarming in a prospective observational study. Crit Care 2014, 18:546.
12. Vaahersalo J., Skrifvars M.B., Pulkki K., et al. Admission interleukin-6 is associated with post resuscitation organ dysfunction and predicts long-term neurological outcome after out-of-hospital ventricular fibrillation. Resuscitation 2014, 85:1573-1579.
13. Green A.R., Shuaib A. Therapeutic strategies for the treatment of stroke. Drug Discov Today 2006, 11:681-693.
14. Miura T., Tanno M. The MPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis. Cardiovasc Res 2012, 94:181-189.
15. Peart J.N., Headrick J.P. Clinical cardioprotection and the value of conditioning responses. Am J Physiol Heart Circ Physiol 2009, 296:H1705-H1720.
16. Blomgren K., Zhu C., Hallin U., et al. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem Biophys Res Commun 2003, 304:551-559.
17. Laver S., Farrow C., Turner D., et al. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126-2128.
18. Chang W.T., Ma M.H., Chien K.L., et al. Postresuscitation myocardial dysfunction: correlated factors and prognostic implications. Intensive Care Med 2007, 33:88-95.
19. Grmec S., Strnad M., Kupnik D., et al. Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation 2009, 80:631-637.
20. Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the acute myocardial infarction study of adenosine (AMISTAD) trial. J Am Coll Cardiol 1999, 34:1711-1720.
21. Ross A.M., Gibbons R.J., Stone G.W., et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005, 45:1775-1780.
22. Piot C., Croisille P., Staat P., et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008, 359:473-481.
23. Kottenberg E., Thielmann M., Bergmann L., et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand 2012, 56:30-38.
24. Carreira R.S., Monteiro P., Kowaltowski A.J., et al. Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion. J Bioenerg Biomembr 2008, 40:95-102.
25. Kunst G., Klein A.A. Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia 2015, 70:467-482.
26. Chow K.Y., Liu S.E., Irwin M.G. New therapy in cardioprotection. Curr Opin Anaesthesiol 2015, 28:417-423.
27. Huang K., Gu Y., Hu Y., et al. Glibenclamide improves survival and neurologic outcome after cardiac arrest in rats. Crit Care Med 2015, 43:e341-e349.
28. Ott I., Schulz S., Mehilli J., et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circ Cardiovasc Interv 2010, 3:408-413.
29. Najjar S.S., Rao S.V., Melloni C., et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA 2011, 305:1863-1872.
30. Fokkema M.L., Vlaar P.J., Vogelzang M., et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circ Cardiovasc Interv 2009, 2:323-329.
31. Desmet W., Bogaert J., Dubois C., et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 2011, 32:867-877.
32. Christopher M., Key C.B., Persse D.E. Refractory asystole and death following the prehospital administration of adenosine. Prehosp Emerg Care 2000, 4:196-198.
33. Walsh R.C., Felice K.L., Meehan T.J., et al. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia. Am J Emerg Med 2009, 27:901 e1-e9012.
34. Lee H.C., An S.G., Choi J.H., et al. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction. Circ J 2008, 72:1425-1429.
35. Ishii H., Ichimiya S., Kanashiro M., et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005, 112:1284-1288.
36. Johnsen J., Pryds K., Salman R., et al. The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection. Basic Res Cardiol 2016, 111:10.
37. Mouton R., Abella B.S., Soar J. Is there a role for remote ischaemic postconditioning in cardiopulmonary resuscitation?. Resuscitation 2010, 81:1476-1478.
38. Hausenloy D.J., Lecour S., Yellon D.M. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 2011, 14:893-907.
39. Hausenloy D.J., Yellon D.M. Reperfusion injury salvage kinase signalling: taking a risk for cardioprotection. Heart Fail Rev 2007, 12:217-234.
40. Dobaczewski M., Xia Y., Bujak M., et al. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 2010, 176:2177-2187.
41. Konstantinov I.E., Arab S., Li J., et al. The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium. J Thorac Cardiovasc Surg 2005, 130:1326-1332.
42. Konstantinov I.E., Li J., Cheung M.M., et al. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a KATP channel-dependent mechanism. Transplantation 2005, 79:1691-1695.
43. 2+ overload. Am J Physiol Heart Circ Physiol 2005, 288:H1900-H1908.
44. Serviddio G., Di Venosa N., Federici A., et al. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J 2005, 19:354-361.
45. Hausenloy D.J., Yellon D.M. The second window of preconditioning (SWOP) where are we now. Cardiovasc Drugs Ther 2010, 24:235-254.
46. Yellon D.M., Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003, 83:1113-1151.
47. Hausenloy D.J. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). Curr Pharm Des 2013, 19:4544-4563.
48. Ong S.B., Dongworth R.K., Cabrera-Fuentes H.A., et al. Role of the MPTP in conditioning the heart - translatability and mechanism. Br J Pharmacol 2015, 172:2074-2084.
49. Li J., Rohailla S., Gelber N., et al. Microrna-144 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol 2014, 109:423.
50. Pytte M., Sun S., Tang W., et al. Ischemic post-conditioning following global ischemia due to cardiac arrest failed to improve cardiac function and survival. Circulation 2008, 118:S1456.
51. Xu J., Sun S., Lu X., et al. Remote ischemic pre and post conditioning produced similar improvement of myocardial and cerebral function in a rat model of cardiac arrest and resuscitation. Circulation 2013, 128:A9.
52. Xu J., Sun S., Lu X., et al. Remote ischemic post conditioning improves the outcomes of cardiopulmonary resuscitation in a rat model of cardiac arrest. Circulation 2013, 128:A170.
53. Grunewald M., Broch O., Albrecht M., et al. Remote ischemic postconditioning in direct post-cardiac arrest period: an animal study. Circulation 2011, 124:A159.
54. Albrecht M., Meybohm P., Broch O., et al. Evaluation of remote ischaemic post-conditioning in a pig model of cardiac arrest: a pilot study. Resuscitation 2015, 93:89-95.
55. Botker H.E., Kharbanda R., Schmidt M.R., et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010, 375:727-734.
56. Eitel I., Stiermaier T., Rommel K.P., et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized lipsia conditioning trial. Eur Heart J 2015, 36:3049-3057.
57. White S.K., Frohlich G.M., Sado D.M., et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2015, 8:178-188.
58. Yellon D.M., Ackbarkhan A.K., Balgobin V., et al. Remote ischemic conditioning reduces myocardial infarct size in stemi patients treated by thrombolysis. J Am Coll Cardiol 2015, 65:2764-2765.
59. Crimi G., Pica S., Raineri C., et al. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv 2013, 6:1055-1063.
60. Rentoukas I., Giannopoulos G., Kaoukis A., et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv 2010, 3:49-55.
61. Sloth A.D., Schmidt M.R., Munk K., et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 2014, 35:168-175.
62. Meybohm P., Bein B., Brosteanu O., et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 2015, 373:1397-1407.
63. Hausenloy D.J., Candilio L., Evans R., et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 2015, 373:1408-1417.
64. Yao Y.T., Li L.H. Sevoflurane versus propofol for myocardial protection in patients undergoing coronary artery bypass grafting surgery: a meta-analysis of randomized controlled trials. Chin Med Sci J 2009, 24:133-141.
65. Huang C.H., Tsai M.S., Chiang C.Y., et al. Activation of mitochondrial STAT-3 and reduced mitochondria damage during hypothermia treatment for post-cardiac arrest myocardial dysfunction. Basic Res Cardiol 2015, 110:59.
66. Gong P., Hua R., Zhang Y., et al. Hypothermia-induced neuroprotection is associated with reduced mitochondrial membrane permeability in a swine model of cardiac arrest. J Cereb Blood Flow Metab 2013, 33:928-934.
67. Tissier R., Couvreur N., Ghaleh B., et al. Rapid cooling preserves the ischaemic myocardium against mitochondrial damage and left ventricular dysfunction. Cardiovasc Res 2009, 83:345-353.
68. Khaliulin I., Clarke S.J., Lin H., et al. Temperature preconditioning of isolated rat hearts - a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol 2007, 581:1147-1161.
69. Hypothermia after Cardiac Arrest Study G Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556.
70. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
71. Deye N., Cariou A., Girardie P., et al. Endovascular versus external targeted temperature management for out-of-hospital cardiac arrest patients: a randomized controlled study. Circulation 2015, 132:182-193.
72. Nielsen N., Wetterslev J., Cronberg T., et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 2013, 369:2197-2206.
73. Bro-Jeppesen J., Hassager C., Wanscher M., et al. Targeted temperature management at 33 degrees C versus 36 degrees C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: a sub-study of the target temperature management trial. Circ Cardiovasc Interv 2014, 7:663-672.
74. Regragui I., Birdi I., Izzat M.B., et al. The effects of cardiopulmonary bypass temperature on neuropsychologic outcome after coronary artery operations: a prospective randomized trial. J Thorac Cardiovasc Surg 1996, 112:1036-1045.
75. Mora C.T., Henson M.B., Weintraub W.S., et al. The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patients undergoing coronary revascularization. J Thorac Cardiovasc Surg 1996, 112:514-522.
76. Chien G.L., Wolff R.A., Davis R.F., et al. Normothermic range temperature affects myocardial infarct size. Cardiovasc Res 1994, 28:1014-1017.
77. Hale S.L., Kloner R.A. Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol 1997, 273:H220-H227.
78. Duncker D.J., Klassen C.L., Ishibashi Y., et al. Effect of temperature on myocardial infarction in swine. Am J Physiol 1996, 270:H1189-H1199.
79. Schwartz L.M., Verbinski S.G., Vander Heide R.S., et al. Epicardial temperature is a major predictor of myocardial infarct size in dogs. J Mol Cell Cardiol 1997, 29:1577-1583.
80. Yanamoto H., Nagata I., Niitsu Y., et al. Prolonged mild hypothermia therapy protects the brain against permanent focal ischemia. Stroke 2001, 32:232-239.
81. Clark D.L., Penner M., Wowk S., et al. Treatments (12 and 48 H) with systemic and brain-selective hypothermia techniques after permanent focal cerebral ischemia in rat. Exp Neurol 2009, 220:391-399.
82. Zhang R.L., Chopp M., Chen H., et al. Postischemic (1 hour) hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion. Stroke 1993, 24:1235-1240.
83. Florian B., Vintilescu R., Balseanu A.T., et al. Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci Lett 2008, 438:180-185.
84. Lyden P.D., Hemmen T.M., Grotta J., et al. Endovascular therapeutic hypothermia for acute ischemic stroke: ICTUS 2/3 protocol. Int J Stroke 2014, 9:117-125.
85. Rincon F., Friedman D.P., Bell R., et al. Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial. Int J Stroke 2014, 9:646-651.
86. Roberts E., Chase T.N., Tower D.B. GABA in nervous system function 1976, Raven Press, New York.
87. Stratford N., Murphy P. Antioxidant activity of propofol in blood from anaesthetized patients. Eur J Anaesthesiol 1998, 15:158-160.
88. Xia Z., Godin D.V., Ansley D.M. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2T)-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 2003, 59:113-121.
89. Xia Z., Godin D.V., Chang T.K., et al. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2T-isoprostane formation. Can J Physiol Pharmacol 2003, 81:14-21.
90. Buljubasic N., Marijic J., Berczi V., et al. Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. Anesthesiology 1996, 85:1092-1099.
91. Li Y.C., Ridefelt P., Wiklund L., et al. Propofol induces a lowering of free cytosolic calcium in myocardial cells. Acta Anaesthesiol Scand 1997, 41:633-638.
92. Bjelland T.W., Klepstad P., Haugen B.O., et al. Effects of hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients. Drug Metab Dispos 2013, 41:214-223.
93. Bjelland T.W., Klepstad P., Haugen B.O., et al. Concentrations of remifentanil, propofol, fentanyl, and midazolam during rewarming from therapeutic hypothermia. Acta Anaesthesiol Scand 2014, 58:709-715.
94. Bjelland T.W., Dale O., Kaisen K., et al. Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial. Intensive Care Med 2012, 38:959-967.
95. Vernooy K., Delhaas T., Cremer O.L., et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm 2006, 3:131-137.
96. Thal S.C., Timaru-Kast R., Wilde F., et al. Propofol impairs neurogenesis and neurologic recovery and increases mortality rate in adult rats after traumatic brain injury. Crit Care Med 2014, 42:129-141.
97. Sebastiani A., Granold M., Ditter A., et al. Posttraumatic propofol neurotoxicity is mediated via the pro-brain-derived neurotrophic factor-P75 neurotrophin receptor pathway in adult mice. Crit Care Med 2016, 44:e70-e82.
98. Engelhard K., Werner C., Eberspacher E., et al. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 2004, 101:912-917.
99. Wang H., Luo M., Li C., et al. Propofol post-conditioning induced long-term neuroprotection and reduced internalization of AMPAR GluR2 subunit in a rat model of focal cerebral ischemia/reperfusion. J Neurochem 2011, 119:210-219.
100. Kajimoto M., Atkinson D.B., Ledee D.R., et al. Propofol compared with isoflurane inhibits mitochondrial metabolism in immature swine cerebral cortex. J Cereb Blood Flow Metab 2014, 34:514-521.
101. Vandesteene A., Trempont V., Engelman E., et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988, 43(Suppl.):42-43.
102. Branca D., Vincenti E., Scutari G. Influence of the anesthetic 2,6-diisopropylphenol (propofol) on isolated rat heart mitochondria. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1995, 110:41-45.
103. Branca D., Roberti M.S., Lorenzin P., et al. Influence of the anesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria. Biochem Pharmacol 1991, 42:87-90.
104. Branca D., Roberti M.S., Vincenti E., et al. Uncoupling effect of the general anesthetic 2,6-diisopropylphenol in isolated rat liver mitochondria. Arch Biochem Biophys 1991, 290:517-521.
105. Rigoulet M., Devin A., Averet N., et al. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem 1996, 241:280-285.
106. Sztark F., Ichas F., Ouhabi R., et al. Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential. FEBS Lett 1995, 368:101-104.
107. Shirakawa M., Imura H., Nitta T. Propofol protects the immature rabbit heart against ischemia and reperfusion injury: impact on functional recovery and histopathological changes. Biomed Res Int 2014, 2014:601250.
108. Yuan J., Cui G., Li W., et al. Propofol enhances hemoglobin-induced cytotoxicity in neurons. Anesth Analg 2016.
109. Altman D.G., Bland J.M. Absence of evidence is not evidence of absence. BMJ 1995, 311:485.
110. Kharbanda R.K., Nielsen T.T., Redington A.N. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009, 374:1557-1565.
111. Rassaf T., Totzeck M., Hendgen-Cotta U.B., et al. Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res 2014, 114:1601-1610.